Telangana, India

Vellanki Sivaram Prasad


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vellanki Sivaram Prasad: Innovator in Pharmaceutical Chemistry

Introduction

Vellanki Sivaram Prasad is a notable inventor based in Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug formulations. His expertise and dedication have led to advancements that benefit the medical community and patients alike.

Latest Patents

Vellanki Sivaram Prasad holds a patent for "Amorphous trisodium sacubitril valsartan and a process for the preparation thereof." This patent discloses the amorphous form of trisodium sacubitril valsartan and methods for its preparation. His work in this area demonstrates his commitment to improving drug efficacy and patient outcomes. He has 1 patent to his name.

Career Highlights

Prasad is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan has allowed him to work on various innovative projects that aim to enhance drug delivery and effectiveness. His contributions have been instrumental in the development of new pharmaceutical products.

Collaborations

Throughout his career, Vellanki Sivaram Prasad has collaborated with talented professionals in the industry. Some of his notable coworkers include Arabinda Sahu and Siva Koteswara Rao Prathi. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Vellanki Sivaram Prasad is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His patent on amorphous trisodium sacubitril valsartan showcases his innovative spirit and dedication to improving healthcare. His contributions continue to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…